Genix Pharmaceuticals Stock Price Prediction
| GENPF Stock | USD 0.03 0.00 0.00% |
Momentum 53
Impartial
Oversold | Overbought |
Using Genix Pharmaceuticals hype-based prediction, you can estimate the value of Genix Pharmaceuticals from the perspective of Genix Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Genix Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Genix because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Genix Pharmaceuticals after-hype prediction price | USD 0.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Genix |
Genix Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Genix Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Genix Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Genix Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Genix Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Genix Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Genix Pharmaceuticals' historical news coverage. Genix Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 13.71, respectively. We have considered Genix Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Genix Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Genix Pharmaceuticals is based on 3 months time horizon.
Genix Pharmaceuticals Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Genix Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genix Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Genix Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.80 | 13.68 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.03 | 0.03 | 0.00 |
|
Genix Pharmaceuticals Hype Timeline
Genix Pharmaceuticals is currently traded for 0.03. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Genix is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 1.8%. %. The volatility of related hype on Genix Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.03. About 45.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.55. Some equities with similar Price to Book (P/B) outperform the market in the long run. Genix Pharmaceuticals recorded a loss per share of 0.02. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next projected press release will be in a few days. Check out Genix Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Genix Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Genix Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Genix Pharmaceuticals' future price movements. Getting to know how Genix Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Genix Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KOAN | Textmunication Holdings | 0.00 | 0 per month | 11.92 | 0.01 | 28.70 | (19.40) | 104.48 | |
| IGEX | Indo Global Exchange | 0.00 | 0 per month | 9.13 | 0.06 | 33.33 | (25.00) | 58.33 | |
| KHRNF | Khiron Life Sciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KAYS | Kaya Holdings | 0.00 | 0 per month | 10.57 | 0.04 | 34.97 | (20.72) | 78.32 | |
| CVGRF | City View Green | 0.00 | 0 per month | 18.84 | 0.12 | 32.90 | (30.31) | 741.79 | |
| CRYM | Cryomass Technologies | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 0.00 | |
| LVRLF | CordovaCann Corp | 0.00 | 0 per month | 13.54 | 0.06 | 34.62 | (30.77) | 170.29 | |
| TLLTF | TILT Holdings | 0.00 | 0 per month | 0.00 | (0.15) | 17.65 | (28.92) | 128.85 | |
| SHMN | Sohm Inc | 0.00 | 0 per month | 10.04 | (0) | 20.00 | (16.67) | 63.33 | |
| BSPK | Bespoke Extracts | 0.00 | 0 per month | 10.10 | 0.06 | 28.57 | (25.00) | 86.10 |
Genix Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Genix price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Genix using various technical indicators. When you analyze Genix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Genix Pharmaceuticals Predictive Indicators
The successful prediction of Genix Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Genix Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Genix Pharmaceuticals based on analysis of Genix Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Genix Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Genix Pharmaceuticals's related companies.
Story Coverage note for Genix Pharmaceuticals
The number of cover stories for Genix Pharmaceuticals depends on current market conditions and Genix Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Genix Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Genix Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for Genix Pink Sheet analysis
When running Genix Pharmaceuticals' price analysis, check to measure Genix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genix Pharmaceuticals is operating at the current time. Most of Genix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Genix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Genix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |